Clinical Trials Browser

Phase 2 × Ovarian Cancer Recurrent × Clear all

NCT07295132 2025-12-19

RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)

Phase 2 Not yet recruiting

Ovarian Cancer Recurrent

NCT04175470 2025-01-03

Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer

Phase 2 Completed

Ovarian Cancer Recurrent

NCT01332656 2015-12-21

OPSALIN

Phase 2 Completed

Ovarian Cancer Recurrent

NCT01485848 2014-06-10

ESP2011-002

Phase 2 Completed

Ovarian Cancer Recurrent